Business
Novo CEO pledges to fill strategic gaps through outside partnerships
Doustdar tells Bloomberg Novo will seek external innovation to fill gaps
1 Sep 22 3:12 AM · 2d ago · 3 articles · 1 video · 3 sources · development 1 of 1
Novo CEO Mike Doustdar discussed investor confidence and drug testing in an interview with Bloomberg Television, signaling the company's willingness to look outside for strategic and scientific partnerships to expand its obesity offerings.
“We should also have a mindset that we don't have a patent or a monopoly on all the good ideas. When there is a gap, strategically or scientifically, we're looking outside to see how we can fill the gaps.”
Mike Doustdar
Mike Doustdar Novo CEONovo Pharmaceutical company
The whole story articlesvideos the bright band is this development · numbered dots are the others · click one to jump
Sep 22yesterdaynow · 4:45 AM ET
What was reported 1 claim about this development
-
first by Bloomberg.com, 2d ago · also Endpoints News
1 more headline
- Novo’s CEO knows the drugmaker needs to build confidence Endpoints News · 1d ago
On air 1 segment · click to watch, arrow keys to move
All 1 developments of Novo CEO pledges to fill strategic gaps through outside… →
YouTubeNewswiresGoogle News